BG Medicine is a life sciences company focused on the discovery, development and commercialization of novel molecular diagnostics based on biomarkers to improve patient outcomes and contain healthcare costs. BG Medicine discovers biomarkers and is developing its diagnostic product candidates using its proprietary, versatile, and scalable technology platform which integrates and automates the precise measurement, analysis, characterization and interpretation of proteins, and metabolites collected from bodily fluids. For more information about BG Medicine, see www.bg-medicine.com.
Corgenix manufactures the BG Medicine Galectin-3 ELISA product, an in-vitro diagnostic product used in conjunction with clinical evaluation as an aid in assessing the prognosis of patients diagnosed with chronic heart failure.
diaDexus, Inc., based in South San Francisco, California, is focused on the development and commercialization of proprietary cardiovascular diagnostic products addressing unmet needs in cardiovascular disease. The company’s PLAC ® Test ELISA Kit is the only blood test cleared by the FDA to aid in predicting risk for both coronary heart disease and ischemic stroke associated with atherosclerosis, the #1 and #3 causes of death, respectively, in the United States.
Corgenix, under the terms of a five-year agreement, will manufacture and supply the PLAC® Test ELISA product for diaDexus.
Dynex Technologies, Inc. (Chantilly VA) was founded in 1952, and has been a leading innovator in microplate analysis, pipettors, dispensers and dilutors for over fifty years. Today, Dynex designs and manufactures a full range of automated laboratory instruments and associated consumables that enable scientists and clinicians to make breakthrough discoveries, earlier, more-accurate diagnoses – innovations to improve health outcomes and enhance life. From fully automated ELISA instruments and the latest in analysis and control software, Dynex designs products to meet the rigorous demands of the most challenging applications. More information is available at www.dynextechnologies.com
Corgenix distributes several Dynex instruments in the US, including the DSX® Four-Plate Automated ELISA Processing System and the DS2® Two-Plate Automated ELISA Processing System.
Randox is an international diagnostics company, headquartered in the UK. Currently the twenty-third largest diagnostics company in the world, Randox develops, manufactures and markets clinical diagnostic products worldwide. Core products are: Biochip Array Technology; clinical chemistry analyzers and reagents; quality controls and external quality assurance programs; environmental diagnostics; recombinant proteins and antibodies. More information is available at www.randox.com.
Corgenix and Randox are collaborating on the application of some of the Corgenix products to Randox delivery platforms.